Drug application
PROPOXYPHENE COMPOUND 65 (ASPIRIN, CAFFEINE, PROPOXYPHENE HYDROCHLORIDE)
Drugs@FDA ANDA 089025 · TEVA
Key facts
| Drug name | PROPOXYPHENE COMPOUND 65 |
|---|---|
| Active ingredients | ASPIRIN, CAFFEINE, PROPOXYPHENE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 089025 |
| Company | TEVA |
| Dosage forms | CAPSULE, ORAL |
| Strength | 389MG;32.4MG;65MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Mar 29, 1985 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.